Dynavax Technologies Corporation
DVAX
$10.40
$0.100.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.75% | 31.17% | 25.85% | -27.85% | -48.10% |
| Total Other Revenue | -50.49% | -50.83% | -53.57% | -26.45% | 35.12% |
| Total Revenue | 26.66% | 24.76% | 19.36% | -27.79% | -45.65% |
| Cost of Revenue | 23.13% | 7.24% | -5.49% | -29.21% | -48.93% |
| Gross Profit | 28.56% | 37.29% | 38.98% | -27.05% | -43.70% |
| SG&A Expenses | 14.73% | 12.53% | 4.89% | 11.33% | 13.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.59% | 14.94% | 5.18% | -2.76% | -16.94% |
| Operating Income | 165.65% | 94.62% | 102.93% | -107.13% | -108.59% |
| Income Before Tax | -365.28% | -807.11% | 806.57% | -61.31% | -83.52% |
| Income Tax Expenses | 156.33% | 431.90% | 75.42% | 152.02% | -28.29% |
| Earnings from Continuing Operations | -407.00% | -751.37% | 527.44% | -66.50% | -84.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -407.00% | -751.37% | 527.44% | -66.50% | -84.48% |
| EBIT | 165.65% | 94.62% | 102.93% | -107.13% | -108.59% |
| EBITDA | 263.87% | 121.15% | 121.14% | -101.79% | -105.33% |
| EPS Basic | -419.55% | -783.24% | 510.39% | -67.40% | -84.76% |
| Normalized Basic EPS | 93.96% | 267.95% | 647.41% | -77.98% | -89.10% |
| EPS Diluted | -508.33% | -1,009.22% | 382.62% | -65.88% | -84.35% |
| Normalized Diluted EPS | 102.85% | 360.20% | 386.45% | -78.71% | -90.03% |
| Average Basic Shares Outstanding | -3.12% | -0.45% | 1.03% | 1.66% | 1.62% |
| Average Diluted Shares Outstanding | -0.19% | 3.05% | 4.40% | -2.26% | -1.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |